Home > Back to Publisher > Report Information

US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition

Koncept Analytics
November 1, 2011
40 Pages - SKU: KOAN6712213

Abstract Table of Contents Search inside this report Related Reports

Countries covered: United States

PBM companies aim at merging retail pharmacy claims processing, formulary management and home delivery pharmacy services in order to develop and create an integrated product offering for payors. PBM is a high volume and low margin business.

The US prescription volume and expenditure has been increasing over the past years. The number of drugs coming into the US market is expected to speed up in future. More effective strategies are being developed by companies in response to pressures being put on health benefit providers with the intention to keep the medications affordable.

Demand of prescription drugs is expected to increase with the increase in average age of the American population. Medical beneficiaries have increased over the past decade and are expected to increase even further with the increase in aging population in the US. Over the past decade, the US health expenditure as percentage of Gross Domestic Product has also been increasing, thereby creating growth opportunities for PBM players. Life expectancy in the US has reached a new height due to which number of people with chronic condition has also risen.

The report analyzes the US Pharmacy Benefit Management Industry. Rising drug prices, increasing drug utilization and prevalence of chronic diseases are some of the drivers being discussed in the report. Mergers and acquisitions in the PBM industry in the past years have also been discussed.

The competition prevailing in the industry has been analyzed with market share of companies on the basis of source of dispensing. Trends in the industry have also been included focusing on key contract changes, contracts for renewals of the major players and market share of PBM companies adjusted on the basis of acquisitions and contract shifts. This report also profiles the major players of the PBM industry.

1. Pharmacy Benefit Management: 1.1 Who are PBM Managers; 1.2 History of PBMs; 1.3 Retail Dispensing Process & Flow of Funds; 1.4 Mail Dispensing Process and Flow of Funds
2. US Pharmacy Benefit Management (PBM) Market: 2.1 Retail Prescription Drug Spending; 2.2 US Prescription Drugs - Generic Share; 2.3 Top PBMs by Membership; 2.4 Specialty Prescription
3. Key Trends: 3.1 Generic Dispensing Rate: Retail v/s Mail; 3.2 PBM Mergers & Acquisitions; 3.3 US Drug Distribution Market Share; 3.4 Medicaid Pharmacy Program Savings; 3.5 US Annual Pharmaceutical Sales Growth; 3.6 US Healthcare Spending; 3.7 Trends in Specialty Medicine; 3.8 PBMs - Incremental Gross Profit from Generics
4. Key Drivers: 4.1 Aging US Demographics; 4.2 Higher Life Expectancy; 4.3 Increasing Drug Utilization; 4.4 Increasing Prevalence of Chronic Diseases; 4.5 Rising Drug Prices; 4.6 US Healthcare Expenditures as a Percentage of GDP; 4.7 US Prescription Volume and Expenditures
5. PBM Market - Competitive Landscape: 5.1 Competitive Overview; 5.2 Market Share - Retail; 5.3 Market Share - Mail; 5.4 Key Contract Changes
6. Company Profiles: 6.1 Medco Health; 6.2 CVS Caremark; 6.3 Express Scripts
List of Charts: History of PBMs; Retail Dispensing Process & Flow of Funds; Mail Dispensing Process & Flow of Funds; Generics’ Share of US Prescription Drug Market (1996-2009); US Retail Prescription Drug Spending (2009-2017E); Specialty Prescription Volume and Spending for Prime Therapeutics (2009); Generic Dispensing Rate at Retail vs. Mail for Big Three PBMs (Q104-Q410); US Drug Distribution Market Share (2010); US Annual Pharmaceutical Sales Growth (2000-2009); US Healthcare Expenditures Annual Growth Rate (2000-2009); Trends in Specialty Medicine (2010); PBMs - Incremental Gross Profit from Generics (2011E-2015E); Medicare Enrollment (2000-2050E); US Life Expectancy (2000-2035E); Annual Change in Manufacturer Prices for Brand Name/General Drugs (2004-10); US Healthcare Expenditures as a Percentage of GDP (2000-2013E); US Prescription Volume and Expenditures (2000-2009); PBM Total Market Share (2010); PBM Retail Market Share (2010); PBM Mail Market Share (2010); Net Revenue of Medco Health Solutions (2006-2010); Net Revenue of Medco Health Solutions- by Business Segment (2010); Net Revenue of CVS (2006-2010); Net Revenue of CVS- by Business segment (2010); Revenue of Express Scripts (2006-2010)
List of Tables: Top 50 PBMs by Membership (2010); Selective Captive PBMs (2010); Select PBM M&A Transactions (1993-2010); Select PBM M&A Transactions in excess of US$100 million; Potential Medicaid Pharmacy Program Savings for Top 10 States (2012-2021); Top 10 PBMs by Total Rx/ Year (2010); PBM Market Share based on Reported Script Volume -Scripts in millions (2010); PBM Market Share based on Acquisitions/Contract shifts (2010); Key Contract Changes (2011); Large Contracts for Renewal (2011)

More United States Pricing Reports

Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs by GBI Research
Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs ...

Pharmaceutical Pricing, Reimbursement, and Market Access News in the Third Quarter of 2011 by Decision Resources
In the third quarter of 2011, politicians in the United States, Europe, and Japan faced the unpleasant task of having to make substantial budget cuts. ...

Pharmaceutical Pricing, Reimbursement, and Market Access News in the First Quarter of 2011 by Decision Resources
For the international pharmaceutical industry, 2011 began as 2010 ended, with governments in the United States, Europe, and Japan looking to cut costs in the ...

Healthcare Reform in the US - Impact on Pricing and Reimbursement by GlobalData
Healthcare Reform in the US - Impact on Pricing and Reimbursement Summary On 23 March, 2010, the Obama administration brought into effect the Patient Protection and Affordable ...

Pharmaceutical Pricing, Reimbursement, and Market Access News in the First Quarter of 2010 by Decision Resources
Introduction: The first quarter of 2010 was one of the most eventful in recent years with regard to pharmaceutical market access. Several governments introduced major ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition

Share this report

Other tasks

Research Assistance

Related Markets

Pricing Reports

Free Alert Me service